10/19/2022 Categories: Venture Capital Angelini Industries launches Angelini Ventures, with € 300 million commitment
9/3/2019 Angelini Pharma launches lurasidone hydrocloride-based Latuda in Spain for the treatment of shizophrenia
8/29/2019 Angelini Pharma announces the acquisition of two OTC products from Sanofi in Germany and Austria